Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases | SpringerLink
The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches
Post-chemotherapeutic CEA and CA19-9 Are Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Hepatic Resection After Oxaliplatin-based Chemotherapy | Anticancer Research
Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
Cancers Metastatic to the Liver - Surgical Clinics
Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer | NEJM
![PDF] Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/53d1a202ca002484723e7638d4baff00fa9d6d7c/3-Figure1-1.png "PDF] Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions | Semantic Scholar")
PDF] Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions | Semantic Scholar
Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis | BMC Cancer | Full Text
Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence - Journal of Hepatology
Post-chemotherapeutic CEA and CA19-9 Are Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Hepatic Resection After Oxaliplatin-based Chemotherapy | Anticancer Research
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer
Post-chemotherapeutic CEA and CA19-9 Are Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Hepatic Resection After Oxaliplatin-based Chemotherapy | Anticancer Research
Resection of Liver Metastases in Colorectal Cancer in the Era of Expanding Systemic Therapy | Annual Review of Medicine
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases | SpringerLink
Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases | SpringerLink
Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases - Reetta Peltonen, Pia Österlund, Marko Lempinen, Arno Nordin, Ulf-Håkan Stenman, Helena Isoniemi, 2018
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies | British Journal of Cancer
Pattern of carcinoembryonic antigen drop after laparoscopic radiofrequency ablation of liver metastasis from colorectal carcinoma - Ghanamah - 2006 - Cancer - Wiley Online Library
Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications? - ScienceDirect
Understanding The CEA Test in Colon Cancer - CancerConnect
JCM | Free Full-Text | Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT | HTML
The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches
